Page 39 - சூரியன் மருந்து தொழில்கள் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ResearchAndMarkets.com s offering. The global specialty generics market reached a value of US$ 57.3 Billion in 2020. Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don t require costly development and marketing costs. Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administr

United statesUnited kingdomSouth koreaAsia pacificLaura woodPorters five forces analysisOffice hours callTeva pharmaceuticals industriesSandoz international gmbSun pharmaceutical industries ltdE st office hours callAkorn incPfizer incEndo internationalApotex corpValeant pharmaceuticals